Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

Mike Hampton, Rob Brown

Sapio Sciences bolsters leadership team to accelerate AI-driven lab informatics evolution

, 17 March 2025/in E-News /by panglobal

Sapio Sciences has announced significant leadership changes designed to strengthen its position in the AI-driven lab informatics sector. The Baltimore-based company, known for its “science-aware” platform, has appointed Mike Hampton as Chief Commercial Officer while simultaneously establishing a dedicated Scientific Office to enhance its research and development capabilities.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/Scherm­afbeelding-2025-03-17-om-09.07.42-1-e1742199432101.jpg 918 1573 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-17 08:30:002025-03-17 08:30:38Sapio Sciences bolsters leadership team to accelerate AI-driven lab informatics evolution
BioMerieux logo

Ten-minute cardiac diagnostics: bioMérieux’s strategic acquisition targets emergency care transformation

, 17 March 2025/in E-News /by panglobal

bioMérieux has announced the acquisition of SpinChip Diagnostics ASA, a privately held Norwegian company specialising in rapid immunoassay diagnostics. The €138 million deal will see bioMérieux acquire 100% ownership of the company, with a cash outlay of approximately €111 million, accounting for the 20% minority stake bioMérieux has held since March 2024.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/BioMerieux_logo.png 1025 1024 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-17 08:10:402025-03-16 16:12:04Ten-minute cardiac diagnostics: bioMérieux’s strategic acquisition targets emergency care transformation
William J. Kullback

Nuclera enhances its leadership team with the appointment of William J. Kullback as non-executive director

, 16 March 2025/in E-News /by panglobal

Nuclera, the Cambridge-based biotechnology company focused on accelerating protein expression and optimisation, has appointed William J. Kullback to its Board of Directors. The appointment comes as the company implements its global commercial strategy following a successful $75 million series C funding round.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/Nuclera_Kullback.jpg 1920 1814 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-16 16:30:572025-03-16 16:30:57Nuclera enhances its leadership team with the appointment of William J. Kullback as non-executive director
Dr Michael Murray, Dr James Clark, Dr Nel Moore

Glox Therapeutics invigorates leadership team to advance bacteriocin-based antibiotics

, 16 March 2025/in E-News /by panglobal

Glox Therapeutics has announced strategic appointments to accelerate the development of its novel bacteriocin-based antibiotic platform, with Dr Michael Murray joining as Chair and Dr Nel Moore strengthening the Scientific Advisory Board. The Glasgow-based biotechnology company is pioneering a distinctive approach to combating antimicrobial resistance (AMR) through engineered protein bacteriocins that selectively target drug-resistant pathogens.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/Scherm­afbeelding-2025-03-16-om-17.24.26.jpg 816 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-16 16:26:092025-03-16 16:26:09Glox Therapeutics invigorates leadership team to advance bacteriocin-based antibiotics
Eleva Bauer

Eleva strengthens clinical leadership with appointment of Martin Bauer as CMO

, 16 March 2025/in E-News /by panglobal

Eleva, the Freiburg-based biopharmaceutical company specialising in difficult-to-produce biologics via its proprietary moss-based expression system, has announced a significant addition to its leadership team as it prepares to enter a crucial clinical development phase.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/Eleva_Bauer.jpg 1816 1453 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-16 16:02:222025-03-16 16:03:57Eleva strengthens clinical leadership with appointment of Martin Bauer as CMO
Indica Labs

First Swiss public health institute deploys cloud-based digital pathology

, 13 March 2025/in E-News /by panglobal

University of Bern makes landmark move to AWS-powered HALO AP platform for diagnostic tissue analysis

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/Indica-Labs.jpg 953 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-13 05:00:282025-03-11 11:21:03First Swiss public health institute deploys cloud-based digital pathology
synexa

Synexa achieves highest My Green Lab certification for sustainable bioanalytical practices

, 12 March 2025/in E-News /by panglobal

Laboratories are among the most resource-intensive environments in scientific research, consuming vast quantities of energy, water, and disposable materials. However, a growing movement towards sustainable laboratory practices is gaining momentum within the bioanalytical sector, as evidenced by Synexa Life Sciences’ recent achievement.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/synexa.jpg 296 716 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-12 11:50:182025-03-11 11:53:28Synexa achieves highest My Green Lab certification for sustainable bioanalytical practices
JuliaHub

JuliaHub enhances pharmaceutical modelling platform with doubled investment

, 12 March 2025/in E-News /by panglobal

Cambridge-based JuliaHub is strengthening its position in the pharmaceutical sector with significant investment in its CFR Part 11-compliant platform, offering integrated solutions for pharmacometrics, modelling and regulatory compliance.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/JuliaHub.png 183 1210 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-12 11:22:212025-03-11 11:26:12JuliaHub enhances pharmaceutical modelling platform with doubled investment
EG 427

First patient treated with innovative HSV vector therapy for neurogenic bladder

, 12 March 2025/in E-News /by panglobal

The biotechnology sector marks a significant advancement in genetic medicine with EG 427’s achievement in treating neurogenic bladder using a novel herpes-based vector approach.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/EG-427.jpg 350 694 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-12 10:46:292025-03-11 10:54:28First patient treated with innovative HSV vector therapy for neurogenic bladder
Eckert Ziegler 2

Strategic partnership forms bridge between isotope expertise and peptide innovation

, 12 March 2025/in E-News /by panglobal

In a significant development for radiopharmaceutical advancement, isotope technology provider Eckert & Ziegler has established a comprehensive partnership with Bicycle Therapeutics to supply radioisotopes and manufacture novel bicyclic peptide-based radiopharmaceuticals for upcoming clinical trials.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/03/Eckert-Ziegler_2.jpg 172 532 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-03-12 10:19:472025-03-11 10:20:22Strategic partnership forms bridge between isotope expertise and peptide innovation
Page 12 of 228«‹1011121314›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription